Regulatory Affairs and Drug Approval

Regulatory Affairs and Drug Approval focuses on the processes and policies governing the development, evaluation, and authorization of pharmaceuticals. This track will explore global regulatory frameworks, submission requirements, and approval pathways across major agencies like FDA, EMA, and others. Topics include compliance, clinical trial regulations, documentation standards, and post-marketing surveillance. Emphasis will be placed on aligning scientific innovation with regulatory expectations to ensure the timely delivery of safe, effective, and high-quality medicines to patients.

 

    Related Conference of Regulatory Affairs and Drug Approval

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Regulatory Affairs and Drug Approval Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in